CAH Posts Strong Cash Flow, Eyes Next Steps in Capital Deployment

Core Insights - Cardinal Health (CAH) is experiencing strong cash generation in fiscal 2026, with approximately $1.8 billion in adjusted free cash flow, enhancing its capital allocation flexibility [1][10] Financial Performance - CAH has returned about $1 billion to shareholders, comprising $750 million in share repurchases and $250 million in dividends, reflecting management's commitment to delivering near-term value [2][10] - The company allocated around $240 million to capital expenditures to support organic growth initiatives [2] Balance Sheet and Leverage - CAH's leverage ratio has improved to 3.2x, within the targeted range of 2.75x to 3.25x, enhancing financial flexibility and allowing for potential capital deployment opportunities [3][5] Capital Allocation Strategy - The company is adopting a disciplined and opportunistic approach to capital deployment, balancing reinvestment in high-growth areas with returns to shareholders [4][5] - While large-scale M&A is not a strategic necessity, CAH remains open to targeted acquisitions in fragmented markets like at-Home Solutions and specialty services [5] Market Position and Valuation - CAH's shares have surged 42.4% over the past six months, outperforming the industry growth of 14.4% [13] - The company trades at a forward price-to-earnings ratio of 19.09, above the industry average and its five-year median of 13.47 [14] - The Zacks Consensus Estimate for CAH's fiscal 2026 earnings indicates a 25.1% increase from the previous year [15]